(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CLINICAL FUSION

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CLINICAL FUSION

ST13

US500000075652331

Class

9

Filing

75652331

Registration

2453785

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

11/08/2022

Trademark type

Word

Nice classes

9

Filing date

02/25/1999

Registration date

05/22/2001

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/30/2022

Last transaction

10/28/2022

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/01/1999

First use in commerce

01/01/1999

Drawing code

1

Owner type

60

Owner location

Denver, CO, US

Examiner

ALI, STEPHANIE MARIE

Law office

L30

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

The Regents of the University of Colorado, a body corporate
THE REGENTS OF THE UNIVERSITY OF COLORADO
U. C. (pessoa física)

Representatives

THE REGENTS OF THE UNIVERSITY OF COLORADO

Technical classification

Nice Classes

Class 9

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

COMPUTER SOFTWARE FOR DATABASE MANAGEMENT AND THE TRACKING AND ANALYZING OF PATIENT RECORDS

Publications

History of USPTO decisions and trademark events.

37 publications found

NURC

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

11/08/2022

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/30/2022

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

09/30/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/30/2022

C.7C

NEW CERTIFICATE UNDER SECTION 7 - PROCESSED

09/30/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/28/2022

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

07/25/2022

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

01/25/2022

PRAM

POST REGISTRATION ACTION MAILED - SEC. 7

01/25/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/06/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/28/2021

E89R

TEAS SECTION 8 & 9 RECEIVED

05/22/2021

ES7R

TEAS SECTION 7 REQUEST RECEIVED

05/22/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/22/2020

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

02/16/2011

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

02/16/2011

E89R

TEAS SECTION 8 & 9 RECEIVED

02/15/2011

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/14/2007

PLGL

ASSIGNED TO PARALEGAL

11/14/2007

E815

TEAS SECTION 8 & 15 RECEIVED

11/08/2007

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

11/07/2007

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/01/2007

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/01/2007

CFIT

CASE FILE IN TICRS

11/02/2006

R.PR

REGISTERED-PRINCIPAL REGISTER

05/22/2001

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

02/08/2001

DOCK

ASSIGNED TO EXAMINER

02/08/2001

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/02/2001

IUAF

USE AMENDMENT FILED

11/29/2000

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

09/19/2000

PUBO

PUBLISHED FOR OPPOSITION

06/27/2000

NPUB

NOTICE OF PUBLICATION

05/26/2000

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/20/2000

CNEA

EXAMINER'S AMENDMENT MAILED

04/14/2000

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/07/2000

CNRT

NON-FINAL ACTION MAILED

08/18/1999

DOCK

ASSIGNED TO EXAMINER

08/13/1999

Continuous trademark protection

Get notified about every new filing that threatens CLINICAL FUSION or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.